Affordable Access

Publisher Website

Early intervention with immunomodulatory agents in the treatment of multiple sclerosis

Journal of the Neurological Sciences
Publication Date
DOI: 10.1016/s0022-510x(02)00039-4
  • Immunomodulatory Agents
  • Multiple Sclerosis
  • Progressive Disease
  • Medicine


Abstract Multiple sclerosis (MS) is a lifelong neurologic disease leading to moderate or severe disability in the majority of affected patients. Studies of the natural history of MS suggest that 90% of patients with relapsing–remitting MS eventually develop secondary progressive (SP) disease. Magnetic resonance imaging (MRI) studies have consistently shown a high frequency of new T2 lesions and new gadolinium enhancing lesions even in the absence of clinical relapse. Lesion burden on T2 MRI increases by 5% to 10% per year and both axonal transection and cerebral atrophy are present at the earliest stages of RR MS. A wealth of evidence suggests that MS is a disease process that is continuously active, and that irreversible damage occurs early in the disease. Despite knowledge of the natural history and the availability of treatments that reduce relapse rates, decrease the accumulation of disability, and decrease surrogate measures of disease activity, only 60% of eligible patients have been treated with immunomodulating agents. This paper reviews the available evidence suggesting that immunomodulatory therapy modifies the natural history of MS and presents an argument for early intervention in the treatment of MS.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Early intervention with immunomodulatory agents in...

on Journal of the Neurological Sc... May 15, 2002

[Early immunomodulatory treatment of multiple scle...

on Neurologia i neurochirurgia po... 2003

[Early immunomodulatory treatment of multiple scle...

on Neurologia i neurochirurgia po... 2001

Immunomodulatory agents for the treatment of relap...

on Archives of internal medicine Oct 28, 2002
More articles like this..